158 related articles for article (PubMed ID: 10440456)
1. Intravenous valproate loading in acutely manic and depressed bipolar I patients.
Grunze H; Erfurth A; Amann B; Giupponi G; Kammerer C; Walden J
J Clin Psychopharmacol; 1999 Aug; 19(4):303-9. PubMed ID: 10440456
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
Martinez JM; Russell JM; Hirschfeld RM
Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
[TBL] [Abstract][Full Text] [Related]
3. Oral loading of sodium valproate compared to intravenous loading and oral maintenance in acutely manic bipolar patients.
Ghaleiha A; Haghighi M; Sharifmehr M; Jahangard L; Ahmadpanah M; Bajoghli H; Holsboer-Trachsler E; Brand S
Neuropsychobiology; 2014; 70(1):29-35. PubMed ID: 25171133
[TBL] [Abstract][Full Text] [Related]
4. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
Müller-Oerlinghausen B; Retzow A; Henn FA; Giedke H; Walden J
J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
[TBL] [Abstract][Full Text] [Related]
5. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
Wheeler A; Robinson G; Fraser A
Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
7. Single-dose intravenous valproate in acute mania.
Phrolov K; Applebaum J; Levine J; Miodovnick H; Belmaker RH
J Clin Psychiatry; 2004 Jan; 65(1):68-70. PubMed ID: 14744171
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness, safety and practicality of delayed-release minitablets of valproate in bipolar affective disorders].
Grunze H; Amann B; Schäfer M; Sterr A; Schaerer L; Wild E; Walden J
Fortschr Neurol Psychiatr; 2000 Nov; 68(11):496-502. PubMed ID: 11144934
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of effectiveness of valproate in neuropsychiatry.
Bowden CL
Expert Rev Neurother; 2007 Jan; 7(1):9-16. PubMed ID: 17187491
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
[TBL] [Abstract][Full Text] [Related]
11. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
12. Correlation of valproate plasma concentrations and dose in bipolar affective disorder.
Perry PJ; Bever-Stille KA; Arndt S; Gundersen S
J Clin Psychopharmacol; 2000 Apr; 20(2):277-9. PubMed ID: 10770477
[No Abstract] [Full Text] [Related]
13. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
Jacobsen FM
J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
[TBL] [Abstract][Full Text] [Related]
14. Acute antimanic efficacy and safety of intravenous valproate loading therapy: an open-label study.
Jagadheesan K; Duggal H; Gupta S; Basu S; Ranjan S; Sandil R; Akhtar S; Nizamie SH
Neuropsychobiology; 2003; 47(2):90-3. PubMed ID: 12707491
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients.
Hirschfeld RM; Allen MH; McEvoy JP; Keck PE; Russell JM
J Clin Psychiatry; 1999 Dec; 60(12):815-8. PubMed ID: 10665626
[TBL] [Abstract][Full Text] [Related]
16. Intravenous valproate in the treatment of acute manic episode in bipolar disorder: A review.
Fontana E; Mandolini GM; Delvecchio G; Bressi C; Soares JC; Brambilla P
J Affect Disord; 2020 Jan; 260():738-743. PubMed ID: 31581039
[TBL] [Abstract][Full Text] [Related]
17. Valproate oral loading in the treatment of acute mania.
Keck PE; McElroy SL; Tugrul KC; Bennett JA
J Clin Psychiatry; 1993 Aug; 54(8):305-8. PubMed ID: 8253698
[TBL] [Abstract][Full Text] [Related]
18. Valproate as a loading treatment in acute mania.
McElroy SL; Keck PE; Tugrul KC; Bennett JA
Neuropsychobiology; 1993; 27(3):146-9. PubMed ID: 8232829
[TBL] [Abstract][Full Text] [Related]
19. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
Ravindran A; Silverstone P; Lacroix D; van Schaick E; Vermeulen A; Alexander J
Clin Pharmacokinet; 2004; 43(11):733-40. PubMed ID: 15301577
[TBL] [Abstract][Full Text] [Related]
20. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
Allen MH; Hirschfeld RM; Wozniak PJ; Baker JD; Bowden CL
Am J Psychiatry; 2006 Feb; 163(2):272-5. PubMed ID: 16449481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
